In late February, PharmedOut launched a new survey, "What Are Your Top 20 Drugs?". We're seeking to find out what drugs healthcare providers would prescribe if they could only pick twenty. We have already received hundreds of responses from 23 different countries, and are excited to analyze the results!
The survey is open through March 7th and is available at http://www.surveymonkey.com/s/Top20Drugs. If you are interested in receiving the results, please send Nicole an email at firstname.lastname@example.org with "survey results" in the subject line.
On February 6, Dr. Fugh-Berman was interviewed on The Diane Rehm Show about "The Risks and Benefits of Prescribing Testosterone" along with Roni Caryn Rabin of The New York Times and "Is It Low-T?" urologist Dr. Harry Fisch. The audio and transcript of the show is available here...
...Which leads us to a new newsletter segment, "PharmedOut Fodder", highlighting a hot topic or recurring story in the news the previous month. We hope you like it!
February's PharmedOut Fodder: Testosterone and Opioids (a tie)
February began with FDA's announcement that they will be evaluating cardiovascular risks of approved testosterone products, in the wake of evidence that this may be a major side effect of the hormone treatment. Four days later, it was announced that five men are suing Androgel maker Abbott Labs after experiencing heart attacks and strokes while using the gel. Concerns about the drug are clearly rising and receiving media attention. PharmedOut continues to work on several papers about testosterone and are glad that ourlongtimequestions about its safety are starting to be addressed.
Also this month, actor Phillip Seymour Hoffman's death of an apparent heroin overdose sparked coverage of opioid addiction, which very often begins with prescription painkillers. Some local governments, and now the Drug Enforcement Administration, have recently taken steps to reclassify hydrocodone and other opioids as Schedule II instead of Schedule III. But problems remain when physicians are rightfully reluctant to give painkillers to addicted patients, who then seek out heroin. We will see if this renewed interest in curbing opioid addiction will lead to action.
PharmedOut's Resource of the Month: Want to learn more about off-label promotion, ghostwriting and more? Check out PharmedOut's publication list.
*** News Round-Up (for more, please follow @pharmed_out on Twitter!)
Don't forget:PharmedOut's Top 20 Drugs survey closes Friday, March 7th at midnight. Please help us by sending the link to any physicians, physician assistants, nurse practitioners, and pharmacists that you know. Thank you!